PROTEIN KINASE INHIBITOR AND USE THEREOF

Title:

PROTEIN KINASE INHIBITOR AND USE THEREOF

Document Type and Number:

WIPO Patent Application WO/2022/086284

Kind Code:

A1

Abstract:

Provided are: a compound of chemical formula 1, having inhibitory activity against protein kinase, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof; and a use thereof.

More Like This:

WO/2014/000178	SULFONAMIDE DERIVATIVES AND METHODS OF USE THEREOF FOR IMPROVING THE PHARMACOKINETICS OF A DRUG
JP2013514973	Tyrosine kinase inhibitor
WO/2014/063638	HOMOPIPERONY LAMINE COMPOUND AND USE THEREOF

Inventors:

BANG KEUK CHAN (KR)
SEO HAENG SOO (KR)
SHIN MI SEON (KR)
AHN JEE YUN (KR)
LEE HYUN JIN (KR)

Application Number:

PCT/KR2021/014942

Publication Date:

April 28, 2022

Filing Date:

October 22, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

MEDYTOX INC (KR)

International Classes:

C07D417/14; A61K31/444; A61K31/497; A61K31/5377; A61P29/00; A61P35/00; A61P37/00

Domestic Patent References:

WO2017168454A2

2017-10-05

Foreign References:

US20180016247A1	2018-01-18
CN106279143A	2017-01-04
KR20200140200A	2020-12-15

Other References:

LI HUI-YING, HE DING-DI, ZHAO XIU-JUAN, SUN TONG-YAN, ZHANG QUAN, BAI CUI-GAI, CHEN YUE: "Design and synthesis of novel dasatinib derivatives as inhibitors of leukemia stem cells", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 28, no. 4, 1 February 2018 (2018-02-01), AMSTERDAM, NL , pages 700 - 706, XP055923165, ISSN: 0960-894X, DOI: 10.1016/j.bmcl.2018.01.011

Attorney, Agent or Firm:

Y.P.LEE, MOCK & PARTNERS (KR)

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHOD AND APPARATUS FOR CONTROLLING SECONDARY CELL GROUP IN A MULTI-RAT DUAL CONNECTIVITY NETWORK

Next Patent: GAP CONFIGURATION FOR UE COMPRISING A PLURALITY OF SIMS IN WIRELESS NETWORK